VRCA

Verrica Pharmaceuticals Inc. - Common Stock (VRCA)

About Verrica Pharmaceuticals Inc. - Common Stock (VRCA)

Verrica Pharmaceuticals, Inc. is a dermatology therapeutics company, which engages in identifying, developing, and commercializing pharmaceutical products for the treatment of skin diseases. Its products include Pipeline VP-102, Pipeline VP-103, and Pipeline VP-315. The company was founded by Matthew Davidson on July 3, 2013 and is headquartered in West Chester, PA.

Details

Daily high

$0.89

Daily low

$0.80

Price at open

$0.86

52 Week High

$7.80

52 Week Low

$0.38

Market cap

75.5M

Dividend yield

0.00%

Volume

346,096

Avg. volume

804,047

P/E ratio

-.68

Verrica Pharmaceuticals Inc. - Common Stock News